All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10294183" target="_blank" >RIV/00064203:_____/13:10294183 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/13:10294183

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.radonc.2013.06.009" target="_blank" >http://dx.doi.org/10.1016/j.radonc.2013.06.009</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.radonc.2013.06.009" target="_blank" >10.1016/j.radonc.2013.06.009</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone

  • Original language description

    Background and purpose: Survival scores for patients with brain metastasis exist. However, the treatment regimens used to create these scores were heterogeneous. This study aimed to develop and validate a survival score in homogeneously treated patients.Materials and methods: Eight-hundred-and-eighty-two patients receiving 10 x 3 Gy of WBRT alone were randomly assigned to a test group (N = 441) or a validation group (N = 441). In the multivariate analysis of the test group, age, performance status, extracranial metastasis, and systemic treatment prior to WBRT were independent predictors of survival. The score for each factor was determined by dividing the 6-month survival rate (in %) by 10. Scores were summed and total scores ranged from 6 to 19 points. Patients were divided into four prognostic groups. Results: The 6-month survival rates were 4% for 6-9 points, 29% for 10-14 points, 62% for 15-17 points, and 93% for 17-18 points (p < 0.001) in the test group. The survival rates were

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Radiotherapy and Oncology

  • ISSN

    0167-8140

  • e-ISSN

  • Volume of the periodical

    108

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    5

  • Pages from-to

    123-127

  • UT code for WoS article

    000324155900019

  • EID of the result in the Scopus database